Unio Biotech, is a biotechnology company based in Kansas specializing in the development of targeted therapies for central nervous system disorders and brain cancers. Our therapeutic approach leverages both protein-based and small molecule based treatments, aimed at addressing the complex biological mechanisms underlying these diseases. Our focus is on delivering effective, safe, and targeted solutions that improve patient outcomes in areas with significant unment medical needs.